Current position:Home >Product >
1H-Benzimidazole-1-carboxylic acid, 4-(bromoacetyl)-2,3-dihydro-3-methyl-2-oxo-, ethyl ester
1H-Benzimidazole-1-carboxylic acid, 4-(bromoacetyl)-2,3-dihydro-3-methyl-2-oxo-, ethyl ester(668275-93-2)
- Name: 1H-Benzimidazole-1-carboxylic acid, 4-(bromoacetyl)-2,3-dihydro-3-methyl-2-oxo-, ethyl ester
- Synonyms:
- Molecular Formula:C13H13BrN2O4
- Molecular Weight:
- CAS Registry Number:668275-93-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.668275-93-2 1H-Benzimidazole-1-carboxylic acid, 4-(bromoacetyl)-2,3-dihydro-3-methyl-2-oxo-, ethyl ester
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 668275-70-5/Carbamic acid, [1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[2-[2-[2-(4-morpholinyl)-2- oxoethoxy]phenyl]-2-oxoethyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 668275-71-6/Carbamic acid, [(3R)-1-[7-(2E)-2-butenyl-2,3,6,7-tetrahydro-3-methyl-1-[2-[2-[[2-(methyl amino)-2-oxoethyl]amino]phenyl]-2-oxoethyl]-2,6-dioxo-1H-purin-8-yl]-3- piperidinyl]-, 1,1-dimethylethyl ester
- 668275-73-8/Isoquinoline, 1-(chloromethyl)-4-methyl-, hydrochloride
- 668275-74-9/Isoquinoline, 1-(chloromethyl)-3,4-dimethyl-, hydrochloride
- 668275-76-1/Quinoline, 8-(chloromethyl)-5-methoxy-, hydrochloride
- 668275-77-2/Imidazo[1,2-a]pyridine, 2-(chloromethyl)-3-methyl-, monohydrochloride
- 668275-78-3/Isoquinoline, 8-(chloromethyl)-5-methoxy-, hydrochloride
- 668275-79-4/5H-Cyclopenta[c]pyridine, 1-(chloromethyl)-6,7-dihydro-3,4-dimethyl-
- 668275-80-7/Isoquinoline, 1-(chloromethyl)-5,6,7,8-tetrahydro-3,4-dimethyl-
- 668275-81-8/Quinoxaline, 7-(chloromethyl)-2,3,5-trimethyl-
- 668275-83-0/Phenanthridine, 6-(chloromethyl)-1,2,3,4-tetrahydro-
- 668275-85-2/1-Naphthalenemethanol, 4-(difluoromethoxy)-
- 668275-86-3/2(3H)-Benzoxazolone, 7-(bromoacetyl)-3-methyl-
- 668275-87-4/Acetamide, 2-[2-(bromoacetyl)phenoxy]-N-ethyl-
- 668275-88-5/2(3H)-Benzoxazolone, 4-(bromoacetyl)-3-methyl-
- 668275-89-6/Acetamide, 2-[2-(bromoacetyl)phenoxy]-N-methyl-
- 668275-90-9/2(3H)-Benzoxazolone, 7-(bromoacetyl)-3-[[2-(trimethylsilyl)ethoxy]methyl]-
- 668275-91-0/2H-Benzimidazol-2-one, 4-(bromoacetyl)-1,3-dihydro-1,3-dimethyl-
- 668275-92-1/2(3H)-Benzoxazolone, 4-(bromoacetyl)-3-[[2-(trimethylsilyl)ethoxy]methyl]-
- 668275-93-2/1H-Benzimidazole-1-carboxylic acid, 4-(bromoacetyl)-2,3-dihydro-3-methyl-2-oxo-, ethyl ester
- 668275-94-3/Ethanone, 2-bromo-1-(2,2-difluoro-1,3-benzodioxol-4-yl)-
- 668275-95-4/Carbamic acid, [1-[7-(2-butynyl)-1-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl)methyl]-2, 3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 668275-96-5/2(3H)-Benzoxazolone, 7-acetyl-3-methyl-
- 668275-97-6/2(3H)-Benzoxazolone, 4-acetyl-3-methyl-
- 668275-98-7/2H-Benzimidazol-2-one, 4-acetyl-1,3-dihydro-1,3-dimethyl-
- 668275-99-8/1H-Benzimidazole-1-carboxylic acid, 4-acetyl-2,3-dihydro-3-methyl-2-oxo-, ethyl ester
- 668276-01-5/Carbamic acid, [1-[7-(2-butynyl)-1-[[1-(2-cyanoethyl)-1H-benzimidazol-2-yl]methyl]-2,3,6, 7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 668276-03-7/Carbamic acid, [1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1-[[1-(phenylmeth yl)-1H-benzimidazol-2-yl]methyl]-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 668276-04-8/Carbamic acid, [1-[1-[2-[2-[(cyanomethyl)amino]phenyl]-2-oxoethyl]-2,3,6,7-tetrahydro-3 -methyl-7-(3-methyl-2-butenyl)-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 668276-05-9/4-Quinazolinamine, 2-(chloromethyl)-N,N-dimethyl-